Work

Supplementary Figure 6 from The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells

Year: 2023

Type: supplementary-materials

Abstract: Response to entrectinib on AML patient samples with TP53 mutations in vivo and expression of RUNX1 isoforms in AML patient samples and MOLM13 parental and CRISPR modified cells.

DOI: 10.1158/2159-8290.22536124.v1

Authors: Tamilla Nechiporuk, Stephen E. Kurtz, Olga Nikolova, Tingting Liu, Courtney L. Jones, Angelo D'Alessandro, Rachel Culp-Hill, Amanda d'Almeida, Sunil K. Joshi, Mara Rosenberg, Cristina E. Tognon, Alexey V. Danilov, Brian J. Druker, Bill H. Chang, Shannon K McWeeney, Jeffrey W. Tyner

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362567486

Cites:

Cited by:

Related to: 10